Explore more publications!

LATAM Daily Brief: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Daily Brief.

Press releases published on November 7, 2025

Taseko to Release Third Quarter 2025 Results
Lithium Argentina to Release PPG Scoping Study Results with Third Quarter 2025 Earnings
InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
Andorinha by Matthias Ambros Wins Silver in A' Furniture Design Awards
El Reconocido Vocalista Terry Ilous Presenta su Apasionante Nuevo Sencillo y Video Musical 'Mentiras'
BTW Media Launches Fascinating Series: 'History of the Internet'
XS.com obtiene dos galardones en el Dubai Affiliate Summit: “Mejor Programa de Afiliados” y “Mejor Soporte”
XS.com conquista duas vitórias no Dubai Affiliate Summit: Melhor Programa de Afiliados e Melhor Suporte
Anachronist Wellness Hosts Global Sports Injury Recovery Masterclass in the Bahamas
ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB)
KalikAI, el chatbot de IA para la comunidad holística de Argentina, alcanza cobertura nacional
Jet.AI and Consensus Core Complete Second Milestone of Canadian Hyperscale Data Center Project
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
Trained Therapeutix Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025
Celldex to Present at Upcoming Investor Conferences

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions